Effect of magnesium hydroxide on the absorption and efficacy of tolbutamide and chlorpropamide

[1]  Neuvonen Pj,et al.  The effects of magnesium hydroxide on the absorption and efficacy of two glibenclamide preparations. , 1991 .

[2]  P. Neuvonen.  The effect of magnesium hydroxide on the oral absorption of ibuprofen, ketoprofen and diclofenac. , 1991, British journal of clinical pharmacology.

[3]  K. Alberti,et al.  The relationships between dose and concentration of tolbutamide and insulin and glucose responses in patients with non-insulin-dependent diabetes , 1991, European Journal of Clinical Pharmacology.

[4]  P. Neuvonen,et al.  Enhancement of absorption and effect of glipizide by magnesium hydroxide , 1991, Clinical pharmacology and therapeutics.

[5]  H. Beck-Nielsen,et al.  Acute Actions of Sulfonylurea Drugs During Long-Term Treatment of NIDDM , 1990, Diabetes Care.

[6]  H. Lebovitz,et al.  Sulfonylureas Why, Which, and How? , 1990, Diabetes Care.

[7]  S. Coppack,et al.  Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus. , 1990, British journal of clinical pharmacology.

[8]  R. Gugler,et al.  Effects of Antacids on the Clinical Pharmacokinetics of Drugs , 1990, Clinical pharmacokinetics.

[9]  J. Horn,et al.  Glipizide Pharmacokinetics: Effects of Age, Diabetes, and Multiple Dosing , 1989, Journal of clinical pharmacology.

[10]  J. Gerich.  Oral hypoglycemic agents. , 1989, The New England journal of medicine.

[11]  L. Groop,et al.  HYPERGLYCAEMIA AND ABSORPTION OF SULPHONYLUREA DRUGS , 1989, The Lancet.

[12]  E. Kraegen,et al.  Physiological Importance of Deficiency in Early Prandial Insulin Secretion in Non-Insulin-Dependent Diabetes , 1988, Diabetes.

[13]  H. Ikegami,et al.  Interindividual variation in the absorption of glibenclamide in man. , 1986, Acta endocrinologica.

[14]  A. Burden,et al.  Improved effect of tolbutamide when given before food in patients on long-term therapy. , 1984, British journal of clinical pharmacology.

[15]  G. Sartor,et al.  Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects , 1980, European Journal of Clinical Pharmacology.

[16]  A. Hurwitz.  Antacid Therapy and Drug Kinetics , 1977, Clinical pharmacokinetics.

[17]  J. Batch,et al.  The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and c-peptide levels , 2006, European Journal of Clinical Pharmacology.

[18]  S. Onorato,et al.  Cisapride and gastric emptying of a solid meal in dyspeptic diabetics without autonomic neuropathy and in healthy volunteers , 2004, European Journal of Clinical Pharmacology.

[19]  G. Sartor,et al.  Improved effect of glibenclamide on administration before breakfast , 2004, European Journal of Clinical Pharmacology.

[20]  A. Melander,et al.  The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia , 2004, European Journal of Clinical Pharmacology.

[21]  P. Neuvonen,et al.  Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids , 2004, European Journal of Clinical Pharmacology.

[22]  P. Neuvonen,et al.  Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide , 2004, European Journal of Clinical Pharmacology.

[23]  P. Neuvonen,et al.  The effects of magnesium hydroxide on the absorption and efficacy of two glibenclamide preparations. , 1991, British journal of clinical pharmacology.

[24]  L. Groop,et al.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. , 1989, Drugs.

[25]  Khalil Sa,et al.  In vitro antidiabetics-antacid interactions. , 1980 .